✨ Your Portfolio is fetched and updated from zerodha.
Small Hospitals

Dr. Lal Pathlabs Ltd.

LALPATHLAB

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹25,910 Cr.
P/E
50.50

Dr. Lal Pathlabs Ltd.

  • Dr. Lal Pathlabs
  • Vijaya Diagnostic
  • Metropolis Health.
  • TJI Diagnostic Chains
FAQs on Dr. Lal Pathlabs Ltd. Shareprice

Dr. Lal Pathlabs has given lower returns compared to its competitors.
Dr. Lal Pathlabs has grown at ~8.5% over the last 3yrs while peers have grown at a median rate of 19.16%

Dr. Lal Pathlabs is not expensive.
Latest PE of Dr. Lal Pathlabs is 51.84, while 3 year average PE is 68.58.
Also latest EV/EBITDA of Dr. Lal Pathlabs is 35.89 while 3yr average is 39.34.

View FAQ's On Business
Growth Table
  • Dr. Lal Pathlabs Ltd.
  • Vijaya Diagnostic
  • Metropolis Health.
Balance Sheet
  • Dr. Lal Pathlabs Ltd.
  • Vijaya Diagnostic
  • Metropolis Health.
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Dr. Lal Pathlabs Ltd.
  • Vijaya Diagnostic
  • Metropolis Health.
Cash Flow
  • Dr. Lal Pathlabs Ltd.
  • Vijaya Diagnostic
  • Metropolis Health.
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Dr. Lal Pathlabs Ltd.
  • Vijaya Diagnostic
  • Metropolis Health.
Quarterly Results
  • Dr. Lal Pathlabs Ltd.
  • Vijaya Diagnostic
  • Metropolis Health.
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Dr. Lal Pathlabs Ltd. Financials

Balance sheet of Dr. Lal Pathlabs is strong.
It shouldn't have solvency or liquidity issues.

The net debt of Dr. Lal Pathlabs is decreasing.
Latest net debt of Dr. Lal Pathlabs is -₹1,674.78 Crs as of Mar-25.
This is less than Mar-24 when it was -₹1,575.46 Crs.

Yes, profit is increasing.
The profit of Dr. Lal Pathlabs is ₹518 Crs for TTM, ₹487 Crs for Mar 2025 and ₹358 Crs for Mar 2024.

The company seems to pay a good stable dividend.
Dr. Lal Pathlabs latest dividend payout ratio is 41.18% and 3yr average dividend payout ratio is 46.36%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech